Medication-Related Osteonecrosis of the Jaw
MRONJ
It refers to a condition in which exposed jawbone or bone that can be felt through a fistula does not heal for more than 8 weeks in a person who is currently taking or has previously taken bone resorption inhibitors (such as bisphosphonates or denosumab) used for osteoporosis or cancer treatment, either alone or in combination with antiangiogenic agents or immunomodulatory drugs. This diagnosis is made when the patient has not received radiation therapy to the jaw and cancer has not spread to the jawbone.[1]
- Standard Term
- Medication-Related Osteonecrosis of the Jaw
- Common Name
- MRONJ
- English
- Medication-related osteonecrosis of the jaw
- Medical Subject Headings (MeSH)
- Bisphosphonate-Associated Osteonecrosis of the Jaw Broader Concept
- Category
- Dental Implant
Plain Language Explanation
It is a condition in which exposed jawbone or bone that can be felt through a small opening (fistula) does not heal for a prolonged period in a person who has taken certain medications used for osteoporosis, cancer treatment, or other conditions.
Easily Confused Terms
| Term | Definition |
|---|---|
| Medication-Related Osteonecrosis of the Jaw | A condition in which exposed jawbone or bone that is palpable through a fistula fails to heal for more than 8 weeks in patients who are currently taking or have previously taken bone resorption inhibitors (such as bisphosphonates or denosumab) used to treat osteoporosis or cancer, either alone or in combination with antiangiogenic agents or immunomodulatory drugs. |
| Peri-Implantitis | Peri-implant diseases are classified into peri-implant mucositis, in which inflammation is confined to the mucosa, and peri-implantitis, in which mucosal inflammation is accompanied by progressive loss of the bone supporting the Dental Implant. |
Medication-related osteonecrosis of the jaw is drug-related damage to the jawbone, while peri-implantitis is a condition in which the bone around a Dental Implant is lost due to bacterial inflammation.
Frequently Asked Questions
It refers to a condition in which exposed jawbone or bone that can be felt through a fistula does not heal for more than 8 weeks in a person who is currently taking or has previously taken bone resorption inhibitors (such as bisphosphonates or denosumab) used for osteoporosis or cancer treatment, either alone or in combination with antiangiogenic agents or immunomodulatory drugs. (Reference 1)
Medication-related osteonecrosis of the jaw is drug-related damage to the jawbone, while peri-implantitis is a condition in which the bone around a Dental Implant is lost due to bacterial inflammation. The definitions of both terms can be found in their respective glossary entries.
This diagnosis is made when the patient has not received radiation therapy to the jaw and cancer has not spread to the jawbone. (Reference 1)
Paper Q&A That Mention This Term
Evidence List
- Ruggiero SL, Dodson TB, Aghaloo T, et al.. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. J Oral Maxillofac Surg. 2022;80(5):920-943. PMID 35300956 · DOI 10.1016/j.joms.2022.02.008
Read More
This is a description from a public medical information website.
Authorship and Review
- Reviewing Clinician
- Young Woo SON, Lead DentistD.D.S., Yonsei University College of Dentistry · M.S., New York University (NYU) College of Dentistry · Ph.D. in Prosthodontics, Yonsei University College of Dentistry
- Written by
- New York Yonsei Dental Clinic Medical Information Editorial Team · Editorial Policy
- Literature Review Date
- 2026.11.01
- Clinician Review Date
- Displayed after director's review
New York Yonsei Dental Clinic Treatment Guide
Treatments related to medication-related osteonecrosis of the jaw are described in the section below.
This terminology explanation is for general medical information purposes only and does not substitute for an individual diagnosis. Whether and how to proceed with treatment will be determined after a clinical examination and consultation.